Provided by Tiger Trade Technology Pte. Ltd.

SBP GROUP

5.760
+0.1452.58%
Volume:21.64M
Turnover:124.44M
Market Cap:107.61B
PE:38.03
High:5.780
Open:5.740
Low:5.715
Close:5.615
52wk High:9.017
52wk Low:4.190
Shares:18.68B
HK Float Shares:18.68B
Volume Ratio:3.44
T/O Rate:0.12%
Dividend:0.12
Dividend Rate:2.12%
EPS(LYR):0.151
ROE:14.07%
ROA:7.51%
PB:2.83
PE(LYR):38.03
PS:2.74

Loading ...

Sino Biopharmaceutical - Launches New Global Brand Sbp Group

THOMSON REUTERS
·
Aug 19

Sino Biopharma Launches SBP Group Global Brand to Drive International Expansion

Reuters
·
Aug 19

Sino Biopharma Rebrands Global Operations Under SBP Group Identity

Reuters
·
Aug 19

China Biopharmaceuticals (01177) Mid-Year Review: Betting Big on AI and Global Expansion as Twin Growth Engines

Stock News
·
Aug 19

SBP Group H1 2026 Results: Revenue Climbs 10.6%, Innovative Drug Sales Surge 44.3%

Bulletin Express
·
Aug 19

Sino Biopharmaceutical Sets HKD 0.07 Interim Dividend, Payable 24 September 2026

Bulletin Express
·
Aug 19

Sino Biopharmaceutical H1 Revenue up 10.6% on Innovative Drug Sales

Reuters
·
Aug 19

SBP Group Profit Attributable to Owners Rises 1.4% to RMB 3.43 Billion in 1H FY26; Revenue Climbs 10.6% to RMB 19.44 Billion

Reuters
·
Aug 19

Sino Biopharm Declares 2026 Interim Dividend of HKD 0.07 a Share

Reuters
·
Aug 19

Sino Biopharmaceutical H1 Revenue RMB 1,944 Million

THOMSON REUTERS
·
Aug 19

Sino Biopharmaceutical - Interim Dividend of Hk7 CENTS\nPER Share

THOMSON REUTERS
·
Aug 19

Ping an Healthcare Names Yougang Zhu Chairman in Board Reshuffle

Reuters
·
Aug 18

Sino Biopharmaceutical Stock Falls 2.0% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 14

Sino Biopharmaceutical Stock Sheds 1.5% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 12

Earning Preview: SBP GROUP Q2 revenue is expected to increase, and institutional views are cautiously positive

Earnings Agent
·
Aug 12

Sino Biopharmaceutical Stock Sheds 0.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Aug 10

Movement Alert|SBP GROUP Rises 3.83% in Regular Trading, Beimosubai Plus Anlotinib Lung Squamous Cell Carcinoma Indication Approved

Market Focus
·
Aug 10

SK Hynix Greenlights 54 Trillion Won Chip Expansion; Beijing Slashes Homebuying Tax Threshold for Non-Local Families to One Year

Stock News
·
Aug 10

Sino Biopharmaceutical Says NMPA Approves Benmelstobart

Reuters
·
Aug 08

Sino Biopharma Unit Gets China Nod to Market Lung Cancer Drug

MT Newswires Live
·
Aug 07